Jazz Pharmaceuticals plc

JAZZ

Jazz Pharmaceuticals plc

JAZZ

Insider Sentiment (TTM):

Last Purchase:2025-05-12Last Sale:2026-06-15Shares Purchased (TTM):0Shares Sold (TTM):239,250

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:59,667,279Shares Outstanding:61,900,000Institutional Ownership Pct.:96.39%

Earnings Market Reaction:

Filing Date:2026-08-03Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1,620	1,844	1,392	1,326	1,190	1,862	2,413	2,218	1,356	1,443	1,506	1,336
Investments	580	1,030	1,050	720	480	710	580	400	625	375	120	250
Accounts Receivable Net Current	881	836	831	764	714	653	717	724	698	707	706	628
Inventory Net	443	438	417	483	505	493	480	539	543	577	597	612
Prepaid Expense Current	200	150	152	147	164	150	177	155	134	123	185	110
Other Assets Current	245	285	324	315	298	260	262	354	326	315	321	310
Assets Current	3,968	4,583	4,166	3,756	3,350	4,128	4,629	4,390	3,682	3,540	3,435	3,246
Property Plant And Equipment And Finance Lease Rig…	-	203	200	189	185	179	173	176	169	166	170	222
Operating Lease Right Of Use Asset	52	56	59	61	63	49	54	77	73	62	65	65
Intangible Assets Net Excluding Goodwill	4,030	4,204	4,430	4,566	4,769	4,718	4,756	5,144	5,079	5,235	5,418	5,418
Goodwill	1,800	1,805	1,829	1,827	1,844	1,760	1,716	1,805	1,736	1,739	1,753	1,705
Deferred Income Tax Assets Net	926	907	869	846	603	575	560	583	545	508	478	464
Deferred Finance Costs Noncurrent Net	-	7	8	8	9	9	9	4	6	6	6	7
Other Assets Noncurrent	86	95	99	103	121	117	114	75	71	71	67	76
Assets	11,081	11,860	11,659	11,356	10,944	11,535	12,012	12,256	11,362	11,327	11,393	11,204
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	129	100	122	152	89	96	78	85	97	81	103	110
Accrued Liabilities Current	1,030	1,022	1,034	1,002	875	1,064	911	859	801	827	794	770
Long Term Debt Current	1,016	1,031	1,030	1,029	1,028	31	31	31	606	605	605	605
Taxes Payable Current	56	94	56	91	79	32	19	55	52	49	35	89
Liabilities Current	2,231	2,247	2,243	2,274	2,071	1,223	1,039	1,030	1,556	1,562	1,537	1,573
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Long Term Debt Noncurrent	3,335	4,324	4,328	4,332	4,336	5,336	6,078	6,081	5,101	5,105	5,108	5,111
Operating Lease Liability Noncurrent	44	47	51	53	55	39	39	71	68	56	59	62
Deferred Income Tax Liabilities Net	529	548	594	629	682	671	677	792	775	810	848	841
Other Liabilities Noncurrent	141	162	125	109	94	91	87	111	99	97	105	127
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	4,332	4,244	4,240	4,086	4,000	3,925	3,914	3,838	3,779	3,714	3,700	3,640
Accumulated Other Comprehensive Income Loss Net Of…	-663	-651	-569	-570	-486	-786	-948	-603	-888	-882	-842	-1,035
Retained Earnings Accumulated Deficit	1,132	939	646	443	191	1,035	1,127	936	871	864	879	884
Stockholders Equity	4,802	4,532	4,319	3,959	3,706	4,175	4,094	4,171	3,763	3,696	3,737	3,489
Liabilities And Stockholders Equity	11,081	11,860	11,659	11,356	10,944	11,535	12,012	12,256	11,362	11,327	11,393	11,204
Allowance For Doubtful Accounts Receivable Current	-	-	17	-	-	-	33	-	-	-	21	-
Common Stock Par Or Stated Value Per Share	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Shares Authorized	-	-	300	-	-	-	300	-	-	-	300	-
Common Stock Shares Issued	-	-	61	-	-	-	61	-	-	-	62	-
Shares Outstanding	-	-	61	-	-	-	61	-	-	-	62	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	11.42%	8.37%	19.60%	-	-	-	-	-	-	-	-	-
2025	6.54%	5.38%	16.55%	20.60%	19.89%	30.78%	28.65%	24.24%	22.95%	3.91%	17.02%	31.61%
2024	-2.96%	-1.21%	-0.26%	-0.45%	-3.16%	0.58%	2.11%	4.64%	2.49%	-3.75%	-28.71%	-24.41%
2023	-	-	-	8.09%	-2.68%	-5.21%	-7.12%	-4.09%	-4.44%	-6.08%	-15.24%	-15.97%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.78	2.04	1.86	1.65	1.62	3.38	4.46	4.26	2.37	2.27	2.24	2.06
Quick Ratio	1.49	1.78	1.60	1.37	1.29	2.85	3.82	3.59	1.93	1.82	1.73	1.60
Working Capital	1.74B	2.34B	1.92B	1.48B	1.28B	2.91B	3.59B	3.36B	2.13B	1.98B	1.90B	1.67B
Leverage & Debt
Debt to Equity	0.46	0.50	0.52	0.57	0.56	0.29	0.25	0.25	0.41	0.42	0.41	0.45
Interest Coverage TTM	5.25	-0.21	-2.21	-2.46	-1.38	2.63	3.01	2.52	2.08	1.84	2.00	0.66
Debt Ratio	0.20	0.19	0.19	0.20	0.19	0.11	0.09	0.08	0.14	0.14	0.13	0.14
Efficiency & Turnover
Asset Turnover TTM	0.42	0.38	0.36	0.35	0.37	0.36	0.35	0.34	0.35	0.34	0.34	0.35
Days Sales Outstanding TTM	63.26	61.23	66.18	65.31	63.06	61.07	63.80	61.77	61.07	63.20	64.60	59.11
Receivables Turnover TTM	5.77	5.96	5.52	5.59	5.79	5.98	5.72	5.91	5.98	5.78	5.65	6.17
Per Share Metrics
Diluted EPS TTM	13.56	0.45	-5.84	-5.98	-6.61	7.91	8.49	7.33	5.67	5.29	5.76	1.12
Free Cash Flow Per Share TTM	25.22	20.48	21.24	22.22	20.87	24.81	21.96	18.40	16.61	16.17	16.88	19.70
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	19.49%	-0.85%	-10.08%	-11.88%	-7.13%	14.63%	17.61%	16.24%	14.34%	13.50%	15.09%	5.08%
Net Profit Margin TTM	20.45%	0.66%	-8.35%	-8.86%	-9.91%	11.86%	13.77%	11.60%	10.10%	8.61%	10.82%	2.11%
Growth Metrics
Net Revenue Growth (1Y)	12.59%	9.20%	4.88%	4.13%	4.52%	5.76%	6.12%	5.23%	3.91%	2.81%	4.78%	5.87%
Net Income Growth (1Y)	-332.38%	-93.89%	-163.58%	-179.56%	-202.51%	45.78%	35.02%	479.28%	-556.49%	-311.66%	-285.14%	-527.86%
EPS Growth (1Y)	-325.03%	-93.98%	-164.48%	-180.50%	-205.33%	49.46%	38.20%	495.32%	-564.54%	-314.90%	-282.94%	-525.63%
Valuation Metrics
P/E TTM	16.19	397.33	-29.11	-21.71	-16.04	15.70	13.60	14.77	16.99	22.77	18.77	102.18
P/B TTM	3.17	2.58	2.40	2.02	1.75	1.81	1.86	1.64	1.78	2.04	2.08	2.34
P/S TTM	3.31	2.64	2.43	1.92	1.59	1.86	1.87	1.71	1.72	1.96	2.03	2.15
Market Cap	15.23B	11.70B	10.37B	8.00B	6.49B	7.57B	7.62B	6.84B	6.71B	7.53B	7.78B	8.17B
Enterprise Value	17.96B	15.21B	14.33B	12.03B	10.67B	11.08B	11.31B	10.74B	11.06B	11.80B	11.99B	12.55B
Calculated Values
Free Cash Flow TTM	1.59B	1.27B	1.30B	1.35B	1.28B	1.51B	1.36B	1.13B	1.04B	1.01B	1.07B	1.24B
Net Debt	2.73B	3.51B	3.97B	4.04B	4.17B	3.51B	3.70B	3.89B	4.35B	4.27B	4.21B	4.38B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Sale

Owner: Smith, Mark Douglas

Title: -

Shares: 1,157

Price/Share: $230.55

Value: $266,746.35

Shares Owned: 9,680

Relationship: Director

Ownership: Direct

2026-06-10Sale

Owner: Patil, Neena M

Title: EVP & Chief Legal Officer

Shares: 1,200

Price/Share: $231.83

Value: $278,196.00

Shares Owned: 51,549

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Cozadd, Bruce C

Title: -

Shares: 6,000

Price/Share: $235.12

Value: $1,410,720.00

Shares Owned: 372,682

Relationship: Director

Ownership: Direct

2026-05-28Sale

Owner: Patil, Neena M

Title: EVP & Chief Legal Officer

Shares: 1,192

Price/Share: $236.97

Value: $282,468.24

Shares Owned: 52,626

Relationship: Officer

Ownership: Direct

2026-05-28Sale

Owner: Pearce, Samantha

Title: EVP, Chief Commercial Officer

Shares: 6,907

Price/Share: $235.41

Value: $1,625,976.87

Shares Owned: 50,272

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Smith, Mark Douglas	Director	-	Direct	Sale	1,157	230.55	$266,746.35	9,680	4
2026-06-10	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	1,200	231.83	$278,196.00	51,549	4
2026-06-01	Cozadd, Bruce C	Director	-	Direct	Sale	6,000	235.12	$1,410,720.00	372,682	4
2026-05-28	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	1,192	236.97	$282,468.24	52,626	4
2026-05-28	Pearce, Samantha	Officer	EVP, Chief Commercial Officer	Direct	Sale	6,907	235.41	$1,625,976.87	50,272	4
2026-05-22	Mcsharry, Heather Ann	Director	-	Direct	Sale	2,000	241.00	$482,000.00	18,449	4
2026-05-22	Winningham, Rick E	Director	-	Direct	Sale	2,741	241.57	$662,143.37	9,567	4
2026-05-01	Cozadd, Bruce C	Director	-	Direct	Sale	6,000	203.33	$1,219,980.00	378,682	4
2026-04-01	Cozadd, Bruce C	Director	-	Direct	Sale	6,000	190.97	$1,145,820.00	384,682	4
2026-03-09	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	1,287	182.94	$235,443.78	6,512	4
2026-03-03	Cozadd, Bruce C	Director	-	Direct	Sale	6,000	186.89	$1,121,340.00	405,796	4
2026-02-27	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	1,117	190.91	$213,246.47	9,235	4
2026-02-27	Riedel, Norbert G	Director	-	Direct	Sale	3,415	192.00	$655,680.00	7,024	4
2026-02-26	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	55,600	191.73	$10,660,188.00	56,862	4
2026-02-26	Henderson, Mary Elizabeth	Officer	SVP, Technical Operations	Direct	Sale	5,343	194.49	$1,039,160.07	28,728	4
2025-12-09	Henderson, Mary Elizabeth	Officer	SVP, Technical Operations	Direct	Sale	2,238	169.51	$379,363.38	19,508	4
2025-12-05	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	4,660	171.16	$797,605.60	7,012	4
2025-11-26	Cozadd, Bruce C	Director	-	Direct	Sale	77,500	178.59	$13,840,725.00	393,332	4
2025-11-20	Mcsharry, Heather Ann	Director	-	Direct	Sale	3,415	177.78	$607,118.70	20,449	4
2025-11-18	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	5,319	181.86	$967,313.34	7,012	4
2025-11-18	Cozadd, Bruce C	Director	-	Direct	Sale	18,000	181.34	$3,264,120.00	390,826	4
2025-11-18	Winningham, Rick E	Director	-	Direct	Sale	5,500	180.86	$994,730.00	8,893	4
2025-11-17	Iannone, Robert	Officer	EVP, Global Head of R&D & CMO	Direct	Sale	7,159	168.26	$1,204,573.34	72,628	4
2025-10-03	Cozadd, Bruce C	Director	-	Direct	Sale	3,500	140.00	$490,000.00	408,826	4
2025-09-02	Cozadd, Bruce C	Director	-	Direct	Sale	6,000	128.62	$771,720.00	429,973	4
2025-08-01	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	1,000	113.21	$113,210.00	435,973	4
2025-07-01	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	1,000	107.63	$107,630.00	436,973	4
2025-06-03	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	500	110.00	$55,000.00	437,973	4
2025-05-12	Mulligan, Seamus	Director	-	Indirect	Purchase	1,621	103.00	$166,963.00	101,621	4
2025-05-02	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	500	120.00	$60,000.00	438,807	4
2025-04-01	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	1,500	123.75	$185,625.00	440,307	4
2025-03-10	Iannone, Robert	Officer	EVP, Global Head of R&D & CMO	Direct	Sale	2,403	138.41	$332,599.23	79,621	4
2025-03-10	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	1,140	137.81	$157,103.40	7,012	4
2025-03-07	Iannone, Robert	Officer	EVP, Global Head of R&D & CMO	Direct	Sale	7,080	139.11	$984,898.80	82,024	4
2025-03-03	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	6,500	144.25	$937,625.00	464,058	4
2025-02-28	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	773	143.30	$110,770.90	9,485	4
2025-02-27	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	3,800	144.87	$550,506.00	33,318	4
2025-02-03	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	1,500	122.31	$183,465.00	439,744	4
2025-01-02	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	1,500	123.43	$185,145.00	425,525	4
2024-12-02	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	53	122.49	$6,491.97	6,596	4
2024-12-02	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	2,000	121.17	$242,340.00	427,025	4
2024-11-08	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	3,700	123.41	$456,617.00	33,048	4
2024-11-01	Cozadd, Bruce C	Director,Officer	Chairman & CEO	Direct	Sale	1,000	110.84	$110,840.00	428,976	4
2024-09-06	Henderson, Mary Elizabeth	Officer	SVP, Technical Operations	Direct	Sale	1,410	108.30	$152,703.00	14,531	4
2024-06-07	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	163	108.83	$17,739.29	6,596	4
2024-05-03	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	5,000	109.65	$548,250.00	36,629	4
2024-03-07	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	1,768	116.98	$206,820.64	6,596	4
2024-03-01	Johnson, Philip L	Officer	EVP & Chief Financial Officer	Direct	Purchase	12,000	119.65	$1,435,800.00	27,932	4
2023-12-04	Smith, Mark Douglas	Director	-	Direct	Sale	417	119.27	$49,735.59	6,888	4
2023-12-04	Cook, Jennifer E.	Director	-	Direct	Sale	417	119.27	$49,735.59	6,888	4
2023-12-04	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	50	121.39	$6,069.50	5,986	5
2023-09-01	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	1,500	144.25	$216,375.00	29,186	4
2023-08-29	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	142	143.47	$20,372.74	5,986	4
2023-08-15	Patil, Neena M	Officer	EVP & Chief Legal Officer	Direct	Sale	750	139.59	$104,692.50	30,686	4
2023-08-14	Mcsharry, Heather Ann	Director	-	Direct	Sale	1,344	138.16	$185,687.04	16,778	4
2023-08-14	Riedel, Norbert G	Director	-	Direct	Sale	1,241	138.16	$171,456.56	13,705	4
2023-08-14	O'Keefe, Kenneth W	Director	-	Direct	Sale	1,241	138.16	$171,456.56	24,723	4
2023-08-14	Cook, Jennifer E.	Director	-	Direct	Sale	1,241	138.16	$171,456.56	7,305	4
2023-08-14	Carr, Patricia	Officer	SVP, Chief Accounting Officer	Direct	Sale	158	138.16	$21,829.28	6,128	4
2023-08-14	Gray, Peter	Director	-	Direct	Sale	1,241	138.16	$171,456.56	16,068	4
2023-08-14	Sohn, Catherine A.	Director	-	Direct	Sale	1,241	138.16	$171,456.56	14,868	4
2023-08-14	Smith, Mark Douglas	Director	-	Direct	Sale	1,241	138.16	$171,456.56	7,305	4
2023-08-14	Winningham, Rick E	Director	-	Direct	Sale	1,241	138.16	$171,456.56	10,444	4
2023-08-14	Enright, Patrick G	Director	-	Direct	Sale	1,241	138.16	$171,456.56	20,946	4
2023-08-14	Oriordan, Anne	Director	-	Direct	Sale	1,241	138.16	$171,456.56	12,551	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

96.39%

Inst. Shares: 59,667,279

Shares Outstanding: 61,900,000

2025-12-31

91.84%

Inst. Shares: 56,004,648

Shares Outstanding: 60,981,000

2025-09-30

90.19%

Inst. Shares: 54,743,339

Shares Outstanding: 60,696,000

2025-06-30

92.10%

Inst. Shares: 56,361,624

Shares Outstanding: 61,194,000

2025-03-31

87.00%

Inst. Shares: 53,072,874

Shares Outstanding: 61,000,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	59,667,279	61,900,000	96.39%
2025-12-31	56,004,648	60,981,000	91.84%
2025-09-30	54,743,339	60,696,000	90.19%
2025-06-30	56,361,624	61,194,000	92.10%
2025-03-31	53,072,874	61,000,000	87.00%
2024-12-31	52,368,482	61,838,000	84.69%
2024-09-30	50,956,274	61,414,000	82.97%
2024-06-30	49,517,893	62,882,000	78.75%
2024-03-31	49,068,643	62,537,000	78.46%
2023-12-31	47,641,261	63,291,000	75.27%
2023-09-30	47,980,742	63,114,000	76.02%
2023-06-30	48,494,225	63,991,000	75.78%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Jazz Pharmaceuticals plc (JAZZ) — SEC Financial Statements & Analysis

Jazz Pharmaceuticals plc (JAZZ) is a pharmaceutical preparations company, incorporated in L2. Jazz Pharmaceuticals plc trades on Nasdaq as: JAZZ. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Jazz Pharmaceuticals plc reported a 12.59% year-over-year revenue growth, a Debt-to-Equity ratio of 0.46x, a Price-to-Sales (P/S) ratio of 3.31x (TTM), a Price-to-Book (P/B) ratio of 3.17x (TTM), at a market cap of $15.23B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 12.59%
Debt To Equity: 0.46x
P/S TTM: 3.31x
P/B TTM: 3.17x
Market Cap: $15.23B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Jazz Pharmaceuticals plc in?

Jazz Pharmaceuticals plc (JAZZ) operates in the Pharmaceutical Preparations industry.

What is JAZZ's market cap?

Jazz Pharmaceuticals plc (JAZZ) has a market capitalization of $15.23B as of 2026-06-30.

What is JAZZ's P/E ratio?

Jazz Pharmaceuticals plc (JAZZ)'s trailing twelve month P/E ratio is 16.19x as of 2026-06-30.

What exchange does JAZZ trade on?

Jazz Pharmaceuticals plc (JAZZ) trades on the Nasdaq.

Where is Jazz Pharmaceuticals plc incorporated?

Jazz Pharmaceuticals plc is incorporated in Ireland.